New Drug Approvals: December 2006

Date of Approval: December 1, 2006

Company: Alimera Sciences Inc.

Treatment for Seasonal Allergic Conjunctivitis

Alaway is an over-the-counter ophthalmic antihistamine indicated for the temporary relief of itchy eyes associated with pollen, ragweed, grass, animal hair and dander.

Date of Approval: December 15, 2006

Company: EMD Pharmaceuticals and Dey, LP

Treatment for Cyanide Poisoning

Cyanokit contains hydroxocobalamin, an antidote indicated for the treatment of known or suspected cyanide poisoning.

Date of Approval: December 15, 2006

Company: BioSante Pharmaceuticals, Inc.

Treatment for Postmenopausal Symptoms

Elestrin is a fast-drying transdermal gel formulation of bio-identical estradiol indicated for the treatment of moderate-to-severe vasomotor symptoms (hot flashes) associated with menopause.

Date of Approval: December 19, 2006

Company: Janssen, L.P.

Treatment for Schizophrenia

Invega is a once-daily oral atypical antipsychotic indicated for the treatment of schizophrenia.

Date of Approval: December 27, 2006

Company: BioForm Medical, Inc

Treatment for Moderate to Severe Facial Wrinkles

Radiesse is a cosmetic dermal filler, for the long-lasting correction of moderate to severe facial wrinkles and folds.